Evoltra and aspergillosis Patient Reports February 13, 2012

Evoltra Side Effects Report #6006109-3
Evoltra side effect was reported by a Physician from FRANCE on Dec 05, 2008. Male patient, 49 years of age, weighting 176.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: aspergillosis, myelitis. Evoltra dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.